ReviewTherapeutics and clinical risk management2018

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy.

Paola Faverio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.